Showing results (111-120 of 142) with videos related to
Sort By:
Pageof 15
Transplantation Proceedings|December 17, 2011
Cumulative exposure to CD8+ granzyme Bhi T cells is associated with reduced lung function early after lung transplantationA Mohammed, O Ulukpo, E C Lawrence, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 26, 2015
Anti-Leukocyte Function-Associated Antigen 1 Therapy in a Nonhuman Primate Renal Transplant Model of Costimulation Blockade-Resistant RejectionD J Anderson, D J Lo, F Leopardi, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 20, 2008
Expanded nonhuman primate tregs exhibit a unique gene expression signature and potently downregulate alloimmune responsesA Anderson, C L Martens, R Hendrix, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 31, 2017
Lessons Learned: Early Termination of a Randomized Trial of Calcineurin Inhibitor and Corticosteroid Avoidance Using BelataceptK A Newell, A K Mehta, C P Larsen, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2006
A mouse model for polyomavirus-associated nephropathy of kidney transplantsE D Han Lee, C C Kemball, J Wang, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 27, 2010
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)F Vincenti, B Charpentier, Y Vanrenterghem, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 20, 2013
Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT studyL Rostaing, F Vincenti, J Grinyó, et al.Nature|May 30, 1996
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathwaysC P Larsen, E T Elwood, D Z Alexander, et al.Transplantation|June 30, 1998
Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockadeE T Elwood, C P Larsen, H R Cho, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 15, 2013
Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletionD J Lo, D J Anderson, T A Weaver, et al.Pageof 15